Related Experiment Video
Updated: Jun 16, 2026
08:03
Intracavernosal Pressure Recording to Evaluate Erectile Function in Rodents
Published on: June 6, 2018
Dopamine-oxytocin interactions in penile erection
T A Baskerville1, J Allard, C Wayman
1School of Biomedical Sciences, University of Edinburgh, Edinburgh, UK. tab3b@clinmed.gla.ac.uk
The European Journal of Neuroscience
|February 5, 2010
Summary
Dopamine and oxytocin pathways interact in the brain to regulate penile erection in rats. This interaction is context-specific, involving different hypothalamic oxytocin cells depending on the sexual situation.
Area of Science:
- Neuroscience
- Endocrinology
- Behavioral Science
Background:
- Dopamine and oxytocin are key regulators of penile erection.
- Neural circuits and interactions between these systems in specific contexts are not fully understood.
- Hypothalamic areas like MPOA, SON, and PVN are candidate sites due to oxytocin cells and dopaminergic inputs.
Purpose of the Study:
- To elucidate the neural circuitry and dopamine-oxytocin interactions in penile erection.
- To investigate the role of specific dopamine receptor subtypes in erectile function.
- To determine if these interactions are context-dependent.
Main Methods:
- Used double immunofluorescence to identify dopamine receptors on oxytocin cells in rat hypothalamus.
- Administered dopamine agonists and oxytocin receptor antagonists in anesthetized and conscious rats.
- Measured intracavernous pressure and monitored neuronal activation (e.g., PVN, SON) as indicators of erectile response.
Main Results:
- Oxytocin cells in MPOA, SON, and PVN express dopamine D(2), D(3), and D(4) receptors.
- Dopamine agonist-induced erections involved oxytocin pathways, modulated by receptor type and behavioral context.
- D(2)/D(3) agonists activated PVN oxytocin cells during erection without a female.
- D(4) antagonists inhibited erection with a female, correlating with SON activation.
Conclusions:
- Dopamine influences hypothalamic oxytocin cells during penile erection in a context-specific manner.
- Different dopamine receptor subtypes and oxytocin cell populations (parvocellular vs. magnocellular) mediate erectile responses.
- The SON and PVN act as crucial integration sites for dopamine-oxytocin interactions in sexual behavior.
Related Concept Videos
01:17Male Sexual Response: Erection & Ejaculation
Sexual stimulation can take various forms, such as physical touch and visual or auditory cues. When this happens, the parasympathetic reflex in the sacral portion of the spinal cord is activated. This reflex stimulates the release of nitric oxide (NO), which then dilates the arterioles in the penis, increasing blood flow to the erectile tissues - the corpora cavernosa and corpus spongiosum.
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
01:31Neurotransmitters
Neurotransmitters are essential chemical messengers within the nervous system, facilitating the communication between neurons. These chemical messengers, varying in function and effect, are critical for sustaining various aspects of neurological health and emotional well-being.
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
01:25Adrenergic Agonists: Indirect-Acting Agents
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
01:28Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
01:28Nitric Oxide Signaling Pathway
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...